Largest health care pharmaceutical companies by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Johnson & Johnson leads the 52 health care pharmaceutical companies ranked by revenue, at HUF 32.05T, ahead of Eli Lilly (HUF 22.18T) and Merck & Co (HUF 22.12T). Figures as of 20 Nov 2026, 17:40 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 52
- First
- Johnson & JohnsonHUF 32.05T
- Median
- HUF 1.09T
- Combined market value
- HUF 1695.77T
- Countries
- 10
- Not ranked
- 9no revenue on file
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Revenue ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | HUF 32.05T | HUF 221.51T | HUF 92,017.12 | 1.22% up | 31% up | ||
| 2 | Eli LillyLLY · Health Care | HUF 22.18T | HUF 409.84T | HUF 460,112.82 | 0.07% up | 28% up | ||
| 3 | Merck & CoMRK · Health Care | HUF 22.12T | HUF 112.95T | HUF 45,817.99 | 1.38% up | 36% up | ||
| 4 | PfizerPFE · Health Care | HUF 21.3T | HUF 53.34T | HUF 9,358.28 | 0.14% down | 10% up | ||
| 5 | AbbVieABBV · Health Care | HUF 20.81T | HUF 173.43T | HUF 98,117.00 | 1.69% up | 20% up | ||
| 6 | AstraZenecaAZN · Health Care | HUF 19.99T | HUF 92.68T | HUF 59,756.68 | 0.11% up | 4% down | ||
| 7 | NovartisNVS · Health Care | HUF 18.56T | HUF 97.57T | HUF 51,660.94 | 0.39% up | 19% up | ||
| 8 | SanofiSNY · Health Care | HUF 16.47T | HUF 38.05T | HUF 15,844.37 | 1.09% up | 7% down | ||
| 9 | Bristol-Myers SquibbBMY · Health Care | HUF 16.4T | HUF 41.19T | HUF 20,152.57 | 1.51% up | 26% up | ||
| 10 | Novo NordiskNVO · Health Care | HUF 15.61T | HUF 57.56T | HUF 13,059.01 | 1.27% down | 18% down | ||
| 11 | Abbott LaboratoriesABT · Health Care | HUF 15.08T | HUF 61.3T | HUF 35,394.60 | 0.13% up | 19% down | ||
| 12 | GSKGSK · Health Care | HUF 14.76T | HUF 32.82T | HUF 16,375.24 | 0.63% up | 1% up | ||
| 13 | Takeda PharmaceuticalTAK · Health Care | HUF 9.6T | HUF 23.79T | HUF 7,445.76 | 2.20% up | 50% up | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | HUF 5.87T | HUF 15.59T | HUF 13,360.18 | 1.87% up | 59% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | HUF 4.88T | HUF 32.54T | HUF 314,532.48 | 0.20% up | 22% up | ||
| 16 | ViatrisVTRS · Health Care | HUF 4.87T | HUF 7.59T | HUF 6,620.54 | 2.14% down | 90% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | HUF 4.08T | HUF 45.06T | HUF 177,735.29 | 0.31% up | 22% up | ||
| 18 | ZoetisZTS · Health Care | HUF 3.22T | HUF 11.08T | HUF 27,275.05 | 0.79% down | 34% down | ||
| 19 | GrifolsGRFS · Health Care | HUF 2.84T | HUF 1.89T | HUF 2,781.95 | 0.30% down | 2% down | ||
| 20 | BeOne MedicinesONC · Health Care | HUF 1.82T | HUF 15.35T | HUF 134,421.90 | 1.17% down | 15% up | ||
| 21 | Elanco Animal HealthELAN · Health Care | HUF 1.6T | HUF 4.36T | HUF 8,732.10 | 2.40% down | 18% up | ||
| 22 | Jazz PharmaceuticalsJAZZ · Health Care | HUF 1.45T | HUF 5.02T | HUF 78,195.84 | 2.82% down | 34% up | ||
| 23 | GenmabGMAB · Health Care | HUF 1.27T | HUF 10.63T | HUF 17,236.20 | 1.36% down | 69% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | HUF 1.26T | HUF 6.8T | HUF 50,779.57 | 0.95% up | 66% down | ||
| 25 | Dr. Reddy's LaboratoriesRDY · Health Care | HUF 1.22T | HUF 4.23T | HUF 5,068.77 | 0.44% up | 7% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | HUF 1.1T | HUF 4.02T | HUF 20,739.58 | 0.77% down | 12% up | ||
| 27 | United TherapeuticsUTHR · Health Care | HUF 1.08T | HUF 8.06T | HUF 189,313.99 | 0.50% down | 18% up | ||
| 28 | Amneal PharmaceuticalsAMRX · Health Care | HUF 1.03T | HUF 2.51T | HUF 7,193.94 | 1.17% down | 79% up | ||
| 29 | Royalty PharmaRPRX · Health Care | HUF 809.3B | HUF 13.39T | HUF 23,285.03 | 1.04% up | 74% up | ||
| 30 | PTC TherapeuticsPTCT · Health Care | HUF 588.9B | HUF 1.63T | HUF 19,555.34 | 1.47% down | 26% down | ||
| 31 | AlkermesALKS · Health Care | HUF 502.2B | HUF 2.64T | HUF 15,684.43 | 0.19% down | 61% up | ||
| 32 | Legend BiotechLEGN · Health Care | HUF 350.1B | HUF 1.01T | HUF 5,227.01 | 4.60% down | 43% down | ||
| 33 | Madrigal PharmaceuticalsMDGL · Health Care | HUF 326.1B | HUF 3.07T | HUF 132,080.64 | 2.17% down | 28% down | ||
| 34 | Ionis PharmaceuticalsIONS · Health Care | HUF 321.1B | HUF 1.56T | HUF 9,341.24 | 0.84% up | 64% down | ||
| 35 | Arrowhead PharmaceuticalsARWR · Health Care | HUF 282.3B | HUF 2.05T | HUF 14,522.30 | 2.23% down | 8% up | ||
| 36 | Ascendis PharmaASND · Health Care | HUF 271.9B | HUF 5.67T | HUF 86,402.17 | 0.80% down | 22% up | ||
| 37 | Corcept TherapeuticsCORT · Health Care | HUF 259.1B | HUF 2.38T | HUF 21,725.60 | 1.75% down | 16% down | ||
| 38 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | HUF 230.6B | HUF 2.53T | HUF 32,151.54 | 1.01% up | 125% up | ||
| 39 | Axsome TherapeuticsAXSM · Health Care | HUF 217.3B | HUF 2.35T | HUF 44,681.39 | 3.23% down | 9% down | ||
| 40 | TG TherapeuticsTGTX · Health Care | HUF 209.7B | HUF 3.32T | HUF 21,956.16 | 0.55% down | 103% up | ||
| 41 | InsmedINSM · Health Care | HUF 206.4B | HUF 10.84T | HUF 49,411.56 | 0.51% up | 27% down | ||
| 42 | Mirum PharmaceuticalsMIRM · Health Care | HUF 177.4B | HUF 2.17T | HUF 33,197.97 | 2.14% up | 35% up | ||
| 43 | BridgeBio PharmaBBIO · Health Care | HUF 170.9B | HUF 5.12T | HUF 26,291.58 | 1.18% down | 15% up | ||
| 44 | Travere TherapeuticsTVTX · Health Care | HUF 167B | HUF 1.58T | HUF 16,439.89 | 0.02% up | 39% up | ||
| 45 | Ligand PharmaceuticalsLGND · Health Care | HUF 91.2B | HUF 1.97T | HUF 98,516.85 | 0.89% up | 44% up | ||
| 46 | Rhythm PharmaceuticalsRYTM · Health Care | HUF 64.6B | HUF 2.66T | HUF 38,385.84 | 3.42% down | 15% up | ||
| 47 | CytokineticsCYTK · Health Care | HUF 30B | HUF 2.44T | HUF 17,532.26 | 0.12% up | 21% down | ||
| 48 | Protagonist TherapeuticsPTGX · Health Care | HUF 15.7B | HUF 2.72T | HUF 41,728.44 | 1.13% down | 45% up | ||
| 49 | Roivant SciencesROIV · Health Care | HUF 2.8B | HUF 9.59T | HUF 13,241.07 | 0.13% down | 93% up | ||
| 50 | Dianthus TherapeuticsDNTH · Health Care | HUF 692.9M | HUF 1.62T | HUF 28,687.29 | 0.62% down | 105% up | ||
| 51 | Spyre TherapeuticsSYRE · Health Care | HUF 0 | HUF 3.05T | HUF 32,063.07 | 3.49% down | 302% up | ||
| 52 | Praxis Precision MedicinesPRAX · Health Care | HUF 0 | HUF 2.91T | HUF 104,242.40 | 1.47% down | 83% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 340.3 HUF). 9 companies have no revenue on file and are not ranked here.
Questions and answers
Which health care pharmaceutical companies rank first by revenue?
Johnson & Johnson (HUF 32.05T), Eli Lilly (HUF 22.18T) and Merck & Co (HUF 22.12T) are the top three of the 52 health care pharmaceutical companies ranked by revenue as of 20 Nov 2026, 17:40 UTC.
How many health care pharmaceutical companies are in this ranking?
52 are ranked by revenue. 9 more have no revenue on file and are left out rather than ranked at zero.
What are these health care pharmaceutical companies worth together?
The 52 health care pharmaceutical companies ranked by revenue have a combined market value of HUF 1695.77T as of 20 Nov 2026, 17:40 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest health care pharmaceutical companies by revenue”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.